about
Ebola Virus Disease: Focus on ChildrenContraceptive methods and risk of HIV acquisition or female-to-male transmissionPooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission.Relationship between social cognitive theory constructs and self-reported condom use: assessment of behaviour in a subgroup of the Safe in the City trialNational estimates of hospital use by children with HIV infection in the United States: analysis of data from the 2000 KIDS Inpatient Database.Trends in hospitalizations of HIV-infected children and adolescents in the United States: analysis of data from the 1994-2003 Nationwide Inpatient Sample.Diabetes trends among delivery hospitalizations in the U.S., 1994-2004.A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN Study.Neutrophil count in African mothers and newborns and HIV transmission risk.Evaluating nurses' implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, MalawiAddition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi.Tenofovir use and renal insufficiency among pregnant and general adult population of HIV-infected, ART-naïve individuals in Lilongwe, MalawiSafety of tenofovir during pregnancy for the mother and fetus: a systematic review.Lymphocytic choriomeningitis virus: an emerging obstetric pathogen?Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions.The use of biomarkers of semen exposure in sexual and reproductive health studies.Sporadic contraceptive use and nonuse: age-specific prevalence and associated factorsReducing lost to follow-up in a large clinical trial of prevention of mother-to-child transmission of HIV: the Breastfeeding, Antiretrovirals and Nutrition study experience.Prevention of perinatal HIV transmission: a review of novel strategies.Recent trends in hepatic diseases during pregnancy in the United States, 2002-2010.Contraceptive availability during an emergency response in the United States.Adherence to extended postpartum antiretrovirals is associated with decreased breast milk HIV-1 transmission.Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants.Breast milk and HIV-1: vector of transmission or vehicle of protection?Optimal methods for collecting and storing vaginal specimens for prostate-specific antigen testing in research studiesHIV-HBV coinfection--a global challengeEvaluation of a volunteer community-based health worker program for providing contraceptive services in Madagascar.The thymus during HIV disease: role in pathogenesis and in immune recovery.Prevention of mother-to-child transmission of HIV type 1: the role of neonatal and infant prophylaxis.A lipid-based nutrient supplement mitigates weight loss among HIV-infected women in a factorial randomized trial to prevent mother-to-child transmission during exclusive breastfeedingEffect of cytomegalovirus infection on breastfeeding transmission of HIV and on the health of infants born to HIV-infected mothers.Health outcomes of HIV-exposed uninfected African infantsAntiretroviral Treatment Is Associated With Iron Deficiency in HIV-Infected Malawian Women That Is Mitigated With Supplementation, but Is Not Associated With Infant Iron Deficiency During 24 Weeks of Exclusive Breastfeeding.Complications of cesarean deliveries among HIV-infected women in the United States.Plasma Micronutrient Concentrations Are Altered by Antiretroviral Therapy and Lipid-Based Nutrient Supplements in Lactating HIV-Infected Malawian Women.Impact of daily cotrimoxazole on clinical malaria and asymptomatic parasitemias in HIV-exposed, uninfected infants.Does tenofovir gel or do other microbicide products affect detection of biomarkers of semen exposure in vitro?Effect of topical vaginal products on the detection of prostate-specific antigen, a biomarker of semen exposure, using ABAcards.Complications of common gynecologic surgeries among HIV-infected women in the United States.
P50
Q26824080-8209066F-6BE3-463B-B142-8B5DAF8D23B5Q27027323-9AD4EE3D-42B0-4A27-9075-4CE455BE45CFQ30569674-1124B805-3E2C-446C-AE5A-4AA6997F7E30Q30612391-A2616D6A-AAE2-4891-A220-081BD4C88BCFQ31044043-712CFE76-A479-4B1D-8D5A-42515A15A3C5Q31117424-E9D8386D-BCED-4901-BDA3-9A3ECB89E06CQ33751491-38DEFEB9-9DF7-4A68-B358-15BC3AB8547DQ33763511-325FB70D-B662-49A5-8B41-1C983C148F13Q33946645-80C7BB03-AD54-4F72-ABB9-48FD144D619DQ33970858-F893BF91-2082-4EE5-AE3D-AB6C5ED3436DQ33990216-18B8295E-5CB0-419E-BB8D-883F4A68B7C2Q34033166-AE8FA9C4-6BAC-4A7A-A684-2AF7C7C48B3DQ34358152-D8DB864F-5A65-41A8-99BD-66D3A27AF63AQ34371989-689F36C9-8AB4-4139-BE8A-F33AEB788367Q34531438-648AA827-4E1B-48F4-8A0E-6C2DFBF109CBQ34682617-A01D417C-173F-4D7D-ABC6-1D6DFC65845DQ34844985-936265D7-B7CF-4691-B435-505D95D8B5ECQ35137403-2710152A-5E9D-4DEF-A345-794C3F98E6A7Q35163949-EEA887B9-6228-4095-8E73-610B0D9B8849Q35207628-A5721912-1339-4C98-9869-3BFDF475F62DQ35286801-0737F6FD-ABB4-4F2A-B31C-B6F0F26F431CQ35297614-91EA3962-C628-42CA-B57B-7C64EB41CE59Q35423380-529511D5-C558-4ED2-8B49-E13A4A9C679DQ35542419-151BA120-A1EA-478D-BA3F-EA5217938074Q35598969-72522BCF-A864-45F1-90DB-57703C85C763Q35676063-A7905873-B099-4C90-850A-880AFE20A15CQ35678473-96C91B2D-4AB3-4AE0-9A17-5F670C5F5C4FQ35678478-B5D69965-14C1-4EF3-BE27-EDF419744EF7Q35743658-EF26C08F-A9DB-48C0-A1F3-39F05EF7E730Q35751105-D60E4C98-D54A-4BE6-97E1-C8AFBF684B57Q35753149-0D47197E-F8F0-4013-97DA-474DEF5B55FDQ35825670-4EE47DCD-56D9-46D3-A39B-DE2791ED4BAEQ35825690-C3BB8A98-398E-4184-8B17-3EEF8CB5F99EQ35863995-304B5CAF-3CFC-46E8-946E-1F88CA03EED0Q35874984-030F67F7-8C7F-4814-813D-74A98F9D170DQ35894292-AD671412-C16A-4F89-BBC8-FB5ED0B4CF61Q35975609-8F71F1C1-313F-4165-A027-5A1F5C9A2894Q35990151-B1B03A45-14C8-4ED5-8AAB-BFBEAB83F2B1Q35990156-E607C148-16A4-4784-82C4-D66CE2AFD3E9Q35996572-2C762659-16E1-48CB-AF3D-9120DD3E2C65
P50
subject
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Athena P Kourtis
@nl
Athena P Kourtis
@sl
Athena P. Kourtis
@en
Athena P. Kourtis
@es
type
label
Athena P Kourtis
@nl
Athena P Kourtis
@sl
Athena P. Kourtis
@en
Athena P. Kourtis
@es
prefLabel
Athena P Kourtis
@nl
Athena P Kourtis
@sl
Athena P. Kourtis
@en
Athena P. Kourtis
@es
P1006
P214
P244
P1006
P106
P1153
7006735818
P21
P213
0000 0001 1304 4430
P214
P244
nb2011000273
P31
P496
0000-0003-1585-1310
P734
P735
P7859
lccn-nb2011000273